Assessing differential attrition in clinical trials: self-monitoring of oral anticoagulation and type II diabetes

@article{Heneghan2007AssessingDA,
  title={Assessing differential attrition in clinical trials: self-monitoring of oral anticoagulation and type II diabetes},
  author={Carl Heneghan and Rafael Perera and A AlisonWard and David Andrew Fitzmaurice and Emma Meats and Paul Glasziou},
  journal={BMC Medical Research Methodology},
  year={2007},
  volume={7},
  pages={18 - 18}
}
BACKGROUND Analyzing drop out rates and when they occur may give important information about the patient characteristics and trial characteristics that affect the overall uptake of an intervention. METHODS We searched Medline and the Cochrane library from the beginning of the databases to May 2006 for published systematic reviews that compared the effects of self-monitoring (self-testing) or self-management (self-testing and self-dosage) of oral anticoagulation or self-monitored blood glucose… CONTINUE READING
14 Citations
37 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 37 references

A clinical trial to evaluate Point of Care and Patient Self Testing Approaches to International Normalized Ratio of Prothrombin Time Monitoring in an Anticoagulation Clinic

  • S Katz, JE Lafata, S Gooldy, E Peterson
  • 2006
Highly Influential
4 Excerpts

Self-monitoring by patients receiving oral hypoglycaemic agents: a survey and a comparative trial

  • M Gallichan
  • Practical Diabetes
  • 2002
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…